Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
J Clin Pediatr Dent ; 45(4): 239-246, 2021 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-34534305

RESUMO

OBJECTIVE: Regarding the 2011 census in Hungary, the number of children with movement deficiences can be around 7,000. These children with special health care needs are considered to be a vulnerable group even from a dental point of view. In our dental program, we gain comprehensive information about patients' oral health, health behavior, and monitor dental care. STUDY DESIGN: A total of 199 children went through a full pediatric dental examination, children with cerebral palsy were categorized into five different levels (GMFCS) and children without motor disfunction into two groups. We analyzed the df-t and DMF-T values. Oral hygiene routine, dental care, gingivitis, demographic characteristics, nutritional habits odds ratio to df-t and DMF-T were surveyed. RESULTS: The mean df-t and DMF-T was 1.87 and 1.15 out of a total of 199, and the group that scored worse was the GMFCS II. The mean RI (restorative index) was 18.12% and 27% for decidous and permanent teeth, respectively. The prevalence of gingivitis was 66.7%. CONCLUSION: The results of our research point to the fact that children with cerebral palsy have difficulties in developing and maintaining proper oral health due to their disadvantages and therefore require special care and attention.


Assuntos
Paralisia Cerebral , Cárie Dentária , Paralisia Cerebral/complicações , Paralisia Cerebral/epidemiologia , Criança , Índice CPO , Assistência Odontológica , Cárie Dentária/epidemiologia , Hábitos , Humanos , Saúde Bucal , Prevalência
3.
Orthod Craniofac Res ; 19(4): 198-208, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27647720

RESUMO

OBJECTIVES: To test the following two hypotheses: 1) different types of retainers result in distinct levels of biomarkers in gingival crevicular fluid (GCF) and 2) the retainer bonded to all mandibular anterior teeth induces more detrimental outcomes to the periodontium. SETTING AND SAMPLE POPULATION: The Department of Orthodontics at the University of Florida. The population consisted of individuals in the retention phase of orthodontic treatment. MATERIAL AND METHODS: This was a cross-sectional study that enrolled 36 individuals. Subjects in group 1 had retainers bonded to the mandibular canines only. Group 2 consisted of individuals having retainers bonded to all mandibular anterior teeth. Group 3 included patients using mandibular removable retainers. After clinical examination, GCF was collected from the mandibular incisor and biomarker levels were compared between the groups. RESULTS: Plaque accumulation and gingivitis differed significantly among groups, with the highest median values in group 2 subjects. Pairwise comparison of the groups with respect to gingivitis showed significant differences between groups 1 and 2. Significant differences among groups were detected for RANKL, OPG, OPN, M-CSF, MMP-3, and MMP-9. The ratio RANKL/OPG was significantly higher in group 2 subjects, with pairwise comparisons indicating that groups 1 and 2 differed from group 3. CONCLUSION: An association was found between orthodontic retention groups and GCF biomarker levels, which should be further explored in longitudinal studies. The presence of retainers bonded to all anterior teeth seems to increase plaque accumulation and gingivitis.


Assuntos
Biomarcadores/química , Colagem Dentária/efeitos adversos , Colagem Dentária/métodos , Placa Dentária/etiologia , Líquido do Sulco Gengival/química , Retração Gengival/etiologia , Gengivite/etiologia , Incisivo/patologia , Incisivo/fisiopatologia , Contenções Ortodônticas/efeitos adversos , Adolescente , Adulto , Estudos Transversais , Dente Canino , Índice de Placa Dentária , Feminino , Humanos , Proteína Antagonista do Receptor de Interleucina 1/química , Interleucina-1beta/química , Interleucina-6/química , Interleucina-8/química , Fator Estimulador de Colônias de Macrófagos/química , Masculino , Mandíbula , Metaloproteinase 3 da Matriz/química , Metaloproteinase 9 da Matriz/química , Pessoa de Meia-Idade , Desenho de Aparelho Ortodôntico , Osteopontina/química , Osteoprotegerina/química , Índice Periodontal , Ligante RANK/química
4.
J Clin Oncol ; 22(10): 1864-71, 2004 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-15143078

RESUMO

PURPOSE: To assess the cardiac status of the long-term survivors and to estimate the incidence and the features of subclinical cardiotoxicity induced after conventional treatment with doxorubicin for non-Hodgkin's lymphoma or Hodgkin's lymphoma. PATIENTS AND METHODS: We analyzed a group of patients who previously received doxorubicin-based chemotherapy for lymphoma. Echocardiograms were performed at least 5 years after therapy with anthracyclines. Clinical cardiomyopathy was defined by the presence of clinical signs of congestive heart failure (CHF). Subclinical cardiomyopathy was defined by decrease of left ventricular fractional shortening (FS) without clinical signs of CHF. Cumulative dose of doxorubicin, male sex, older age, relapse, radiotherapy (mediastinal or total-body irradiation), autologous stem-cell transplantation, high-dose cyclophosphamide, and cardiovascular risk factors (hypertension, diabetes, hypercholesterolemia, familial history of cardiac disease, being overweight, and smoking history) were evaluated as potential risk factors for the development of cardiac dysfunction. RESULTS: Of 141 assessable patients (median age, 54 years; median cumulative dose of doxorubicin, 300 mg/m(2)), only one developed CHF. Criteria of subclinical cardiomyopathy were found in 39 patients. In multivariate analysis, factors that contributed to decreased FS were male sex (P <.01), older age (P <.01), higher cumulative dose of doxorubicin or association with another anthracycline (P =.04), radiotherapy (P =.04), and being overweight (P =.04). CONCLUSION: Cardiac abnormalities can occur in patients treated with doxorubicin for lymphoma in the absence of CHF, even in patients who received moderate anthracycline doses. Male sex, older age, higher dose of doxorubicin, radiotherapy, and being overweight were risk factors for the development of cardiomyopathy.


Assuntos
Antibióticos Antineoplásicos/efeitos adversos , Cardiomiopatias/epidemiologia , Doxorrubicina/efeitos adversos , Linfoma/tratamento farmacológico , Adulto , Idoso , Idoso de 80 Anos ou mais , Cardiomiopatias/induzido quimicamente , Eletrocardiografia , Feminino , França/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco
5.
Bone Marrow Transplant ; 33(9): 921-3, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15034544

RESUMO

Rituximab, an anti-CD20 monoclonal antibody, is increasingly used in the treatment of B-cell non-Hodgkin's lymphoma. Late-onset neutropenia in relation to rituximab has been recently described. In this report, we present six cases occurring after stem cell transplantation and discuss the potential impact of this complication.


Assuntos
Anticorpos Monoclonais/farmacologia , Antígenos CD20/química , Antineoplásicos/farmacologia , Linfoma não Hodgkin/terapia , Neutropenia/etiologia , Idoso , Anticorpos Monoclonais Murinos , Feminino , Fator Estimulador de Colônias de Granulócitos/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Neutrófilos/metabolismo , Rituximab , Transplante de Células-Tronco , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...